Project Details
Description
An Exploratory, Multicenter, Single-blind, fMRI Study of Fixed-dose Brexpiprazole (OPC-34712) (2 mg/day tablets) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Irritability
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/14 → 9/1/15 |
Funding
- OTSUKA PHARMACEUTICAL CO., LTD.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.